Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3
World
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3
World
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Official URL: https://fevir.net/resources/EvidenceVariable/236950 | Version: 1.0.0-ballot3 | ||||
| Standards status: Informative | Computable Name: GroupAssignment_SGLT2_inhibitors_vs_GLP_1_RA | ||||
| Other Identifiers: FEvIR Object Identifier: FEvIR Object Identifier#236950, FEvIR Linking Identifier: MAGIC-5288-j1Wqrn-group-assignment-85394-85798, OID:2.16.840.1.113883.4.642.40.44.24.148 | |||||
Copyright/Legal: Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse). |
|||||
This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide.
version: 75; Last updated: 2026-08-06 17:15:59+0000
Profile: GroupAssignment
ArtifactPublicationStatus: Active
url: EvidenceVariable GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA
identifier: FEvIR Object Identifier/236950, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-group-assignment-85394-85798, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.24.148
version: 1.0.0-ballot3
name: GroupAssignment_SGLT2_inhibitors_vs_GLP_1_RA
title: GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA
citeAs:
GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236950. Revised 2026-08-06. Available at: https://fevir.net/resources/EvidenceVariable/236950. Computable resource at: https://fevir.net/resources/EvidenceVariable/236950#json.
status: Active
date: 2026-11-05 14:34:28+0000
author: Computable Publishing®: MAGIC-to-FEvIR Converter:
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
description:
This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide.
copyright:
Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).
| Type | Target[x] |
| Part Of | MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report) |
| Concept |
| Defined in handling and category elements |
handling: dichotomous variable
category
name: SGLT2 inhibitors
value: Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors
category
name: GLP-1 RA
IG © 2024+ HL7 International / Clinical Decision Support.
Package hl7.fhir.uv.ebm#1.0.0-ballot3 based on FHIR 6.0.0-snapshot1.
Generated
2026-11-05
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change